Drugs affecting the gastrointestinal system

Application Chondroitin appears to play a regulatory role for chondrocytes, neural cells, and some tumor cells. Chondroitin sulfate B is used to study ß peptide (1-42) cytotoxicity.

Application Chorismic acid is used as a precursor for a number of important biological compounds synthesized via the shikimate pathway such as the aromatic amino acids tyrosine and phenylalanine, indole, ubiquinone, 2,3-dihydroxybenzoic acid (DHB),

Application Chorismic acid is used as a precursor for a number of important biological compounds synthesized via the shikimate pathway such as the aromatic amino acids tyrosine and phenylalanine, indole, ubiquinone, 2,3-dihydroxybenzoic acid (DHB),

Application Chorismic acid is a metabolite generally used in the study of chorismate-prephenate rearrangement and to synthesize chorismate derivatives. Intermediate in the biosynthesis of aromatic amino acids via the shikimate pathway.

Application Chorismic acid is a metabolite generally used in the study of chorismate-prephenate rearrangement and to synthesize chorismate derivatives. Intermediate in the biosynthesis of aromatic amino acids via the shikimate pathway.

Application Chorismic acid is a metabolite generally used in the study of chorismate-prephenate rearrangement and to synthesize chorismate derivatives. Intermediate in the biosynthesis of aromatic amino acids via the shikimate pathway.

Application Chorismic acid is a metabolite generally used in the study of chorismate-prephenate rearrangement and to synthesize chorismate derivatives. Intermediate in the biosynthesis of aromatic amino acids via the shikimate pathway.

Natiave chymotrypsin from human pancreas. Increased levels of this enzyme and/or its zymogen have been found in serum of individuals with cystic fibrosis.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Biochem/physiol Actions H 2 histamine receptor antagonist I 1 imidazoline receptor agonist anti-ulcer agent. Blocks cancer metastasis by inhibiting the expression of E-selectin on the surface of endothelial cells, thus blocking tumor cell

Biochem/physiol Actions H 2 histamine receptor antagonist I 1 imidazoline receptor agonist anti-ulcer agent. Blocks cancer metastasis by inhibiting the expression of E-selectin on the surface of endothelial cells, thus blocking tumor cell